[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-359967-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-359967-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","targeting-cell-membrane-sphingolipids-a-novel-ceramide-analog-cey-b1-inhibits-migration-and-invasion-in-cervical-cancer-cells","Targeting cell membrane sphingolipids: a novel ceramide analog CeY-B1 inhibits migration and invasion in cervical cancer cells","","Cervical cancer remains a leading cause of cancer-related mortality in women worldwide, with poor outcomes driven by persistent chemotherapy resistance and repeated recurrence, making new therapeutics essential. CeY-B1, a synthesized ceramide analog, was assessed in cervical cancer cell lines using viability, colony formation, migration, invasion, apoptosis, and cell-cycle assays. Lipidomics quantified sphingolipid metabolic changes, while network pharmacology predicted targets and pathways and qPCR/Western blot confirmed key signaling proteins. Xenograft studies evaluated antitumor efficacy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/targeting-cell-membrane-sphingolipids-a-novel-ceramide-analog-cey-b1-inhibits-migration-and-invasion-in-cervical-cancer-cells/359967/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/targeting-cell-membrane-sphingolipids-a-novel-ceramide-analog-cey-b1-inhibits-migration-and-invasion-in-cervical-cancer-cells/359967.png","ImageObject",300,407,{"name":42,"@type":43},"Melati","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-19","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is CeY-B1 and how was it tested in cervical cancer cells?","Question",{"text":63,"@type":64},"CeY-B1 is a synthesized ceramide analog. It was evaluated using cell viability, colony formation, migration, invasion, apoptosis, and cell cycle assays in cervical cancer cell lines.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What did lipidomics show after CeY-B1 treatment?",{"text":68,"@type":64},"Lipidomics indicated accumulation of specific ceramide species, especially Cer(t18:0/24:1), Cer(t18:0/24:0), and Cer(d18:1/24:0(2OH)), supporting activation of the sphingolipid signaling pathway.",{"name":70,"@type":61,"acceptedAnswer":71},"Which signaling mechanisms were linked to CeY-B1’s effects?",{"text":72,"@type":64},"Mechanistic results showed CeY-B1 increased ASK1 and phosphorylated JNK while decreasing Bcl-2. The work suggests activation of the ASK1-JNK axis and inhibition of the PI3K/AKT pathway contribute to apoptosis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},359967,1791600376,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962085570644,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Tang et al. Journal of Translational Medicine (2026) 24:640  \n[https://doi.org/10.1186/s12967-026-08031-2](https://doi.org/10.1186/s12967-026-08031-2)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nTargeting cell membrane sphingolipids:  a novel ceramide analog CeY-B1 inhibits migration and invasion in cervical cancer cells  \nWeiwei Tang1†, Hongliang Ma1†, Jingjing Li1, Yunxia Kuang1, Xiuqiong Meng1, Ruyu Zeng1, Tianli Yu1, L. M. Yin3, Yongmin Zhang3,4, Yanli Cui2* and Jiangchao Li1*  \nAbstract  \nBackground Cervical cancer remains one of the leading causes of cancer-related mortality among women worldwide. The prognosis of cervical cancer is poor due to persistent chemotherapy resistance and repeated recurrence; therefore the development of new drugs is crucial.  \nMethods CeY-B1 is a ceramide analogue that we synthesized and evaluated in cervical cancer cell lines using cell viability assays, colony formation, migration, invasion, apoptosis, and cell cycle assays. We performed lipidomics analysis to assess changes in sphingolipid metabolism after CeY-B1 treatment. Furthermore, we conducted network pharmacology analysis to predict potential molecular targets and signaling pathways. We further detected key signaling proteins using qPCR and Western blot analysis. Finally, we evaluated the antitumor efficacy of CeY-B1 in a subcutaneous xenograft mouse model.  \nResults In this study, we synthesized a ceramide analog CeY-B1, which inhibited the proliferation, migration, and invasion of cervical cancer cells, induced apoptosis and cell cycle arrest, and suppressed tumor growth in a xenograft mouse model. Lipidomics results showed that CeY-B1 treatment led to the accumulation of specific ceramide species, especially Cer(t18:0/24:1), Cer(t18:0/24:0), and Cer(d18:1/24:0(2OH)), indicating that the sphingolipid signaling pathway was activated. Network pharmacology revealed 78 common target genes between CeY-B1 and cervical cancer, and identified enriched pathways including PI3K/AKT signaling, MAPK signaling, and oxidative stress response. Mechanistic studies showed that CeY-B1 upregulated ASK1 and phosphorylated JNK while downregulated Bcl-2 .  \nLipid sequencing and network pharmacology showed that the ASK1-JNK pathway was activated and the PI3K/AKT pathway was inhibited in the sphingolipid signaling cascade, both of which contribute to cell apoptosis.  \nConclusions These findings support the potential of CeY-B1 as a novel therapeutic agent for cervical cancer, via the regulation of ceramide metabolism, cell survival, and apoptotic pathways.  \n†Weiwei Tang and Hongliang Ma contributed equally to this work.  \n*Correspondence: Yanli Cui [cuiyl@zju.edu.cn](cuiyl@zju.edu.cn)[ ](cuiyl@zju.edu.cn)Jiangchao Li  \n[lijiangchao@gdpu.edu.cn](lijiangchao@gdpu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.or","cbCaidGq01skJ1Eb","https://ap.wps.com/l/cbCaidGq01skJ1Eb","pdf",2479101,15,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Standard treatments and resistance in cervical cancer\n## Role of ceramide in apoptosis and signaling","[{\"question\":\"What is CeY-B1 and how was it tested in cervical cancer cells?\",\"answer\":\"CeY-B1 is a synthesized ceramide analog. It was evaluated using cell viability, colony formation, migration, invasion, apoptosis, and cell cycle assays in cervical cancer cell lines.\"},{\"question\":\"What did lipidomics show after CeY-B1 treatment?\",\"answer\":\"Lipidomics indicated accumulation of specific ceramide species, especially Cer(t18:0/24:1), Cer(t18:0/24:0), and Cer(d18:1/24:0(2OH)), supporting activation of the sphingolipid signaling pathway.\"},{\"question\":\"Which signaling mechanisms were linked to CeY-B1’s effects?\",\"answer\":\"Mechanistic results showed CeY-B1 increased ASK1 and phosphorylated JNK while decreasing Bcl-2. The work suggests activation of the ASK1-JNK axis and inhibition of the PI3K/AKT pathway contribute to apoptosis.\"}]","Targeting cell membrane sphingolipids: a novel ceramide analog CeY-B1 inhibits migration and invasion in cervical cancer cells | PDF",1790138347,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d387c33476d79eeff3e6d9dc798cf85.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68f011b5039c4889c4c33f263dceb337.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/19fb763aa9cac37e79e5e43c9a52c353.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/22fdb5600796b49af87d6241a7616503.webp",980,1306]